ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2214

Contrary to Current Understanding of Osteoarthritis Pathogenesis, Only Gender and Radiographic Status Predict Progression: A Machine Learning Study of 9,254 Knees from the Osteoarthritis Initiative

Michael A Bowes1, Oras Alabas2, Gwenael Guillard1, Graham R. Vincent1, Alan Brett3 and Philip G. Conaghan4, 1Imorphics Ltd, Manchester, United Kingdom, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, United Kingdom, Leeds, United Kingdom, 3Imorphics Ltd, MANCHESTER, United Kingdom, 4Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Osteoarthritis – Clinical Aspects Poster II: Observational and Epidemiological Studies

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Currently there are a large number of postulated predictors for OA progression, proposed on the basis of relatively small studies (100’s), and measurement approaches involving large error margins. Supervised machine learning techniques, allows the study of key pathologies without prior assumptions, and accurate quantified segmentation. Our aim was to evaluate predictors of cartilage loss in the entire OAI dataset.

Methods:

Automated cartilage segmentation was assessed for repeatability and accuracy and then applied to all knees from the OAI with baseline, 1 and 2-year images. Shape models were used to measure cartilage thickness in a consistent anatomical region of the medial tibiofemoral joint.

Multilevel modelling was used to consider the effects of previous postulated covariates at knee-level and subject-level at baseline and in longitudinal change. Gender, KL grade, race, knee alignment, height and weight, age, pain, physical activity, NSAID use, previous surgery, smoking and systolic blood pressure were used as covariates.

Results:

The segmentation method showed excellent accuracy; miss-n-out validation in a training set of 287 knees with varying radiographic OA, showed a mean point-to-surface accuracy of 0.12 mm, mean 95% error of 0.37mm (less than one voxel edge). 9,254 knees were included; mean age was 61.2 (SD 9.2); 58.5% were female. 24.8% used NSAIDs, 47.2% were smokers, 22.7% had previous surgery.

Gender and KL grade explained almost all the variability in cartilage thickness at baseline; for example, the adjusted pseudo-r2 of femur and tibia models using only gender and KL grade were 38% and 40%, the full models were 40% and 43%, coefficients are provided in Table 1. A similar pattern was found in longitudinal analysis (Table 2); gender and KL grade accounted for almost all the variability in change in thickness.

Conclusion:

This is the first study to characterise the relationship of cartilage thickness, and its change, using a very large dataset. Two covariates explained almost all the variance in thickness: gender and radiographic disease, previously described factors such as weight and alignment (nor NSAIDS and smoking) had surprisingly little effect. This changes our concept of osteoarthritis progression, and potential interventions.


Disclosure: M. A. Bowes, None; O. Alabas, None; G. Guillard, Stryker Corp, 3; G. R. Vincent, Stryker Corp, 3; A. Brett, Stryker Corp, 3; P. G. Conaghan, AbbVie, BMS, Eli Lilly, Novartis, Pfizer, Roche, 5,AbbVie, BMS, Eli Lilly, Novartis, Pfizer, Roche, 8.

To cite this abstract in AMA style:

Bowes MA, Alabas O, Guillard G, Vincent GR, Brett A, Conaghan PG. Contrary to Current Understanding of Osteoarthritis Pathogenesis, Only Gender and Radiographic Status Predict Progression: A Machine Learning Study of 9,254 Knees from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/contrary-to-current-understanding-of-osteoarthritis-pathogenesis-only-gender-and-radiographic-status-predict-progression-a-machine-learning-study-of-9254-knees-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/contrary-to-current-understanding-of-osteoarthritis-pathogenesis-only-gender-and-radiographic-status-predict-progression-a-machine-learning-study-of-9254-knees-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology